US Stem Cell Inc (USRM)

[Xpecht]

Interesting timing on this new flexibility from the FDA. Bring back MyoCell RMAT and while we’re at it the Hungry Hippo as well! Lol

The path wasn’t clear for Tomas and USRM to continue to spend money on the RMAT application. Is the path more clear now?

USRM has spent more than $100 million over two decades on both preclinical (animal) and clinical (human) trials using its MyoCell™ product. The trials published to date show culture-expanded autologous stem cells directly injected into the heart can provide benefit to congestive heart failure patients

(review full publication here: https://www.ncbi.nlm.nih.gov/pubmed/21982657)